6936:HKEXS.F. Holding Co., Ltd. Class H Analysis
Data as of 2026-06-07 - not real-time
NT$34.55
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
VETNOSTRUM is trading just above its 20‑day and 50‑day moving averages but remains under the 200‑day trend line, indicating short‑term momentum within a longer‑term bearish backdrop. RSI sits in the low‑60s and the MACD histogram has turned positive, while volume is on an upward trajectory, suggesting a modest technical bounce. At a dividend yield above 4% the stock offers attractive cash flow, yet the payout ratio is close to 93%, raising questions about long‑term sustainability.
Fundamentally, the company posts solid revenue growth and healthy operating margins, and its DCF‑derived fair value is roughly double the current market price, flagging clear undervaluation. Low beta and modest 30‑day volatility point to a stable risk profile, though regulatory exposure in the animal‑health space and Taiwan‑centric operations introduce medium‑level concerns.
Fundamentally, the company posts solid revenue growth and healthy operating margins, and its DCF‑derived fair value is roughly double the current market price, flagging clear undervaluation. Low beta and modest 30‑day volatility point to a stable risk profile, though regulatory exposure in the animal‑health space and Taiwan‑centric operations introduce medium‑level concerns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above short‑term moving averages
- Positive MACD histogram amid a bearish longer‑term trend
- Increasing trading volume supporting near‑term stability
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value substantially higher than market price
- Consistent revenue growth and solid operating margins
- Attractive dividend yield despite sustainability concerns
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation with strong cash generation
- Low overall volatility and beta indicating defensive profile
- Stable sector fundamentals and growing demand for animal health products
Key Metrics & Analysis
Financial Health
Revenue Growth8.10%
Profit Margin9.52%
P/E Ratio19.0
ROE10.73%
ROA6.58%
Debt/Equity1.58
P/B Ratio1.8
Op. Cash FlowNT$306.1M
Free Cash FlowNT$231.9M
Technical Analysis
TrendBearish
RSI61.3
SupportNT$32.65
ResistanceNT$35.00
MA 20NT$33.49
MA 50NT$34.25
MA 200NT$35.11
MACDBullish
VolumeIncreasing
Fear & Greed Index83.02
Valuation
Fair ValueNT$65.32
GradeUndervalued
TypeBlend
Dividend Yield4.37%
Risk Assessment
Beta-0.05
Volatility14.97%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.